Phosphorylation of eIF2α supports CML progression with a prosurvival role, shown in the inhibition of PERK, which prevents eIF2α phosphorylation [79]. The gene discussed is EIF2A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.